89bio Inc (ETNB)
8.58
-0.34
(-3.81%)
USD |
NASDAQ |
Apr 24, 16:00
8.57
-0.01
(-0.12%)
After-Hours: 20:00
89bio Total Assets (Quarterly): 596.27M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 596.27M |
| September 30, 2023 | 460.11M |
| June 30, 2023 | 492.51M |
| March 31, 2023 | 494.32M |
| December 31, 2022 | 196.82M |
| September 30, 2022 | 200.58M |
| June 30, 2022 | 147.60M |
| March 31, 2022 | 135.76M |
| December 31, 2021 | 162.42M |
| September 30, 2021 | 168.06M |
| Date | Value |
|---|---|
| June 30, 2021 | 181.71M |
| March 31, 2021 | 198.65M |
| December 31, 2020 | 211.07M |
| September 30, 2020 | 223.43M |
| June 30, 2020 | 76.56M |
| March 31, 2020 | 87.69M |
| December 31, 2019 | 95.55M |
| September 30, 2019 | 18.35M |
| June 30, 2019 | 22.35M |
| December 31, 2018 | 11.37M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.35M
Minimum
Sep 2019
596.27M
Maximum
Dec 2023
219.46M
Average
181.71M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 640.55M |
| Akero Therapeutics Inc | 580.27M |
| Viking Therapeutics Inc | 368.49M |
| Galectin Therapeutics Inc | 28.20M |
| Terns Pharmaceuticals Inc | 268.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 59.96M |
| Shareholders Equity (Quarterly) | 536.31M |